Neutralizing monoclonal antibodies (nMAbs) elicited against foot-and-mouth disease virus (FMDV) of serotype C were assayed with field isolates and variant FMDVs using several immunoassays. Of a total of 36 nMAbs tested, 23 recognized capsid protein VP1 and distinguished at least 13 virion conformationindependent epitopes involved in neutralization of FMDV C. Eleven epitopes of FMDV C-S8cl have been located in segments 138-156 or 192-209 of VP1 by quantifying the reactivity of nMAbs with synthetic peptides and with nMAb-resistant mutants of FMDV C-S8cl carrying defined amino acid substitutions. The main antigenic site of FMDV C-S8cl (VP1 residues 138 to 150) consists of multiple (at least 10), distinguishable, overlapping epitopes. Some amino acid replacements abolished one of the epitopes, whereas other replacements affected several epitopes in this region. The conservative substitution His(146) --, Arg, found in many nMAb-resistant mutants analysed, abolished the reactivity of the virus with all nMAbs that recognized epitopes in the main antigenic site of FMDV C-S8cl. This indicates that a minimum genetic change can result in a highly amplified phenotypic effect, as regards the antigenicity of FMDV.
Introduction
Foot-and-mouth disease virus (FMDV) is a picornavirus that causes an economically important disease of cattle and other cloven-hoofed animals (reviews in Bachrach, 1968; Brown, 1979; Pereira, 1981 ; Domingo et al., 1990) . The region around amino acids 140 to 160 of the structural protein VP1 contains a major antigenic determinant for the neutralization of FMDV (Strohmaier et al., 1982; Pfaff et al., 1982; Bittle et al., 1982; Rowlands et al., 1983; Geysen et al., 1984 Geysen et al., , 1985 . This region includes several epitopes (Pfaff et al., 1988; Stave et al., 1988; Thomas et al., 1988; Bolwell et al., 1989; Mateu et al., 1989) and for FMDV of serotype O some of the epitopes also contain residues of VP1 segment 200-213 (Parry et al., 1985 Xie et al., 1987) , thus indicating a complex antigenic structure. Peptides representing this antigenic site may constitute synthetic vaccines for FMD (reviews in Brown, 1988 Brown, , 1989 , but a major drawback for their efficacy is the remarkable potential for antigenic variation of FMDV (Mateu et al., 1987 Gebauer et al., 1988 ; reviewed by Domingo et al., 1990) . Analysis of the reactivity of monoclonal antibodies (MAbs) with field isolates of FMDV type C has shown that very few of the epitopes involved in the neutralization of viral infectivity are conserved (Mateu etal., 1988) . This observation prompted us to suggest that each FMDV isolate is antigenically unique in its fine epitopic composition . This would follow from the quasispecies (extreme genetic heterogeneity) nature of FMDV populations (Domingo et al., 1985 (Domingo et al., , 1990 Steinhauer & Holland, 1987; Domingo & Holland, 1988; Eigen & Biebricher, 1988; Domingo, 1989) . In this view, each isolate would be characterized by an average antigenic composition and individual virions of that isolate may deviate from the average antigenic behaviour (Rowlands et al., 1983; Mateu et al., 1989; Diez et al., 1989) . It is not possible to predict to what extent any given amino acid substitution fixed at an antigenic domain will affect the interaction of the antigen with different antibodies and the nature of this interaction has only recently begun to be clarified at the atomic level (reviews in Mariuzza et al., 1987; Getzoff et al., 1988; Colman, 1988) .
In this report we show that the 138-156 VP1 region of FMDV of serotype C consists of multiple, overlapping epitopes involved in neutralization of viral infectivity. A number of amino: acid substitutions fixed at this antigenic site in the field or in cell culture affected one or a few such epitopes. In contrast, FMDV mutants with the amino acid replacement His(146) -* Arg in VP1 did not react with any of the available neutralizing (n)MAbs that define the different epitopes on that antigenic domain. This result provides direct evidence that certain amino acid substitutions, should they be fixed during virus evolution, can lead to remarkable antigenic change in the major determinant of FMDV.
Methods
Viruses. The origin and preparation of the majority of the FMDV field isolates used in the present study have already been described (Mateu et al., 1987 . In addition, FMDV C1 Vosges (isolated in France, 1960 ), C, Corneze (France, 1966 , C1 Haute Loire (France, 1969) and C~ Bouches du Rh6ne (France, 1978) were also analysed. They were amplified in BHK-21 cells from the original stocks, kindly provided by M. Lombard (Rh6ne M6rieux, Lyon, France). MAbresistant mutants were selected with nMAb 4G3, either from FMDV C-S8cl (C~ Santa Pau; Spain, 1970) or from an nMAb SD6-resistant mutant of this virus, using described procedures . For the selection of nMAb 4G3-resistant mutants, 104 to 105 p.f.u, were incubated for 1 h at 4 °C with a 1:10 dilution of ascitic fluid. Rabbit anti-mouse IgG (Cappel) was then added to a 1:40 dilution and the mixture was further incubated for 1 h at 4 °C and plated with a 1:200 dilution of nMAb 4G3 included in the agar overlay. Unless stated otherwise each MAb-resistant mutant analysed in the present study was selected from virus prepared from a different single plaque, each derived from the three-times plaque-purified FMDV C-S8cl .
Synthetic peptides. Peptides were synthesized manually by solid phase procedures (Merrifield, 1963) on either 4-methylbenzhydrylamine or N-phenylacetyl-p-aminobenzoic acid-type solid supports (Giralt et al., 1981 ; Mateu et al., 1987 Mateu et al., , 1989 . Synthetic protocols were based on the classical butoxycarbonyl/benzoic acid protection strategy and included systematic double coupling for each residue. Following HF cleavage and deprotection, the crude peptides were purified by gel filtration, followed by reverse-phase liquid chromatography to give HPLC-homogeneous (>95~ pure) products, which were further characterized by amino acid analysis and, in most cases, 1H-nuclear magnetic resonance spectroscopy and fast atom bombardment mass spectrometry. After conjugation to keyhole limpet haemocyanin (KLH) the ratio of peptide to KLH was determined by amino acid analysis.
Monoclonal antibodies. MAbs were prepared against FMDV C1 Brescia (Italy, 1964) (Capucci et al., 1984) , FMDV C-S8cl (Mateu et al., 1987) , FMDV C1 Vosges (MAb 8E8, kindly supplied by M. Lombard, Rh6ne M6rieux, Lyon, France) or FMDV C3 Indaial (Brazil, 1971) . Their relevant characteristics are summarized in Table 1 .
Immunological assays. Enzyme-linked immunodot (EID) and enzyme-linked immunoelectrotransfer blot (EITB) assays were as described (Mateu et al., 1987) , except that goat anti-mouse IgG coupled to peroxidase (Bio-Rad, 1:2000 dilution, 1 h at room temperature) was used instead of rabbit anti-mouse IgG and Protein A-peroxidase. Two types of virus neutralization (VN) assays were used. For titration of MAbs against FMDV C~ Brescia, mixtures of 100 TCIDs0 of FMDV C~ Brescia and serial dilutions of supernatant of hybridoma culture were incubated for 1 h at 37 °C and titrated on IBRS-2 cell monolayers grown on multiwell plates (four wells/dilution). At 48 h post-infection titres were calculated using the method of Reed & Muench (1938) . Any other neutralization tests and titres were by a plaque reduction assay, as described in Mateu et al. (1987) .
Nucleotide sequencing. FMDV RNA was sequenced by primer extension and dideoxynucleotide chain termination, as described (Sobrino et al., 1986; Martinez et al., 1988) .
Results
Multiple epitopes in the 140-160 VP1 antigenic site of FMDV of serotype C Seven out of 17 nMAbs produced against FMDV C1 Brescia reacted specifically with VP1 in EITB assays (Table 1 ). These VPl-specific nMAbs revealed four distinct patterns of reactivity in immunoassays with a set of 24 field isolates of FMDV of serotype C (Fig. 1) thus defining, on this basis, at least four distinguishable epitopes. These results, along with conclusions of a previous analysis carried out with 16 VPl-specific nMAbs prepared against FMDV C-S8cl and FMDV C3 Indaial (Mateu et al., 1987 and data not shown), indicate that 23 out of 36 nMAbs elicited with type C viruses are VPl-specific (Table 1 ) and distinguish at least 13 virion conformation-independent epitopes involved in neutralization of FMDVs of serotype C. Eleven of these epitopes are represented in FMDV C-S8cl (see groups in Table 1) .
We have used synthetic peptides representing VP1 segments for epitope location. In EID assays 20 VP1-specific nMAbs reacted quantitatively with peptide A 19 (residues 138 to 156 of VP1) and only one nMAb, 7JA1, reacted with peptide C18 (residues 192 to 209 of VP1); none of the conformation-dependent nMAbs reacted with any of the peptides (Table 1 and Fig. 2a ). The epitopes recognized by nMAbs 7AB5 and 7CH1 are not represented in FMDV C-S8cl and have not been located.
A more precise mapping of the different epitopes located in the 130-160 VP1 region was achieved with overlapping peptides (Fig. 2b) . nMAbs 5A2, SD6, 7AHI, 7FC12 and 7EE6 reacted with peptides A24 (residues 133 to 156) and A19 (138 to 156), but not with A13 (144 to 156), A9 (148 to 156) or A7 (150 to 156). Thus, residues from segment 138-143 contribute to the five epitopes recognized by those MAbs. The absence of reactivity with peptide A'9 (136 to 144) suggests that residues from segment 145-156 also participate in these five epitopes, although these residues are not sufficient to produce positive binding with peptide A13. The conclusions of the reactivity of those nMAbs with synthetic peptides are consistent with the observation that nMAb SD6-resistant mutants included replacements at amino acid positions 138, 139 or 146 of VP 1 . 
* VN, virus neutralization assays. Average neutralizing titres (in parentheses) are given. For MAbs against FMDV C 1 Brescia, titres were expressed as the log10 reciprocal dilution of supernatant of hybridoma culture (SHC) that inhibited virus-specific c.p.e, development (100 TCIDso) in 50~ of the wells in a classic microneutralization assay. For the remaining MAbs, titres were given as the log10 reciprocal dilution of SHC that causes neutralization of 70~ of p.f.u, in a plaque reduction assay (Mateu et al., 1987) . ( Table 2 and Fig. 3 ). nMAbs 4C4 and 6Dll bound significantly less strongly to peptide A13 than to A19 or A24 (Fig. 2b) , suggesting that residues in segment 138-143 may somehow contribute to the epitopes recognized by these two nMAbs. This was confirmed by results of reactivity of MAb-resistant mutants with nMAbs 4C4 and 6D11 (Fig. 3) . These results, summarized in Fig. 4 (see also below), permit grouping of the epitopes at the 138-156 site of VP1 in two antigenic subregions. Table 2 . A mouse serum against peptide A7 coupled to BSA gave a positive reaction with peptides A24, A19, A13, A9 and A7 coupled to KLH, but not with KLH alone.
A single amino acid substitution affects multiple overlapping epitopes in the 140-160 VP1 antigenic site of FMDV of serotype C W e have quantified the reactivity in i m m u n o a s s a y s of F M D V type C v a r i a n t s w i t h substitutions in the VP1 region a r o u n d a m i n o acids 140 to 160, using V P l -s p e c i f i c n M A b s that define different epitopes. T h e results of reactivity of M A b -r e s i s t a n t m u t a n t s with n M A b s in E I T B assays (Fig. 3) show that the substitutions f o u n d c a n be classified into three groups, according to their effect o n the a n t i g e n -a n t i b o d y interaction. T h e first group is amino acid replacements that affected only one epitope [e.g. Thr(150) ~ Met or Thr(150) ~ Lys, which decreased the binding of nMAb 4G3 only]. The second group includes substitutions that affected several, but not all, of the epitopes within the antigenic site. For example Ala(138) ~ Asp significantly decreased the interaction of the virus with nMAbs SD6, 5A2, 6D11 and 4C4, which recognized four distinguishable epitopes, but did not decrease the interaction with nMAbs 7AH1, 7FC12, 7CAll, 7JD1 and 4G3, which recognized five other epitopes ( Fig. 3 and Table 1 ). In the third group one substitution, His(146)~ Arg, affected all the epitopes defined by our panel of nMAbs in this antigenic region. A high proportion of MAb-resistant mutants independently selected with nMAb SD6 or 4G3 included replacement His(146)~Arg and Table 2 ). They did not react with any of the nMAbs that defined nine epitopes in the 138-156 VP 1 region (Fig. 3) . Thus, a single amino acid substitution was sufficient to affect the binding of all the antibodies that recognized the main antigenic region of this FMDV, even though it consists of multiple epitopes (see Discussion). nMAb 7JA1 recognized an epitope in the C terminus of VP1 (Fig. 2a) and its reactivity was not affected by any of the tested subsitutions in the 138-150 region (Fig. 3) . M. G. Mateu and others When comparing reactivities of MAb-resistant mutants in EITB assays (Fig. 3) with those in EID assays (data not shown) we generally found a good correlation between the two techniques. However, a few exceptions were noted with nMAbs 4C4, 7AH1, 7CA11 and 7EE6. In particular, variants with the substitution His(146) -~ Arg reacted with nMAbs 7AH1 and 7CA11 in the EID assay. Also, nMAb 7EE6 reacted in the same assay with FMDV C-S8cl and all MAb-resistant mutants tested, except those carrying the substitution His(146)-~ Arg. Results of neutralization assays with these viruses and nMAbs paralleled the results of EITB, but not of EID assays. Absence of correlation between binding of some antibodies to virions and neutralization of infectivity has previously been observed for FMDV (Grubman & Morgan, 1986; Mateu et al., 1988; .
Substitutions fixed in the course of a disease episode [Ala(138) ~ Thr, Leu(147) --, Ile and Leu(147) ~ Val in VP1] greatly affect the epitope defined by nMAb SD6 . These substitutions, or others found at positions 140(Ala ~ Thr) and 149(Thr ~ Ala), also affect the epitopes recognized by nMAbs 5A2, 7AH1, 7FC12 and 7CAll, but not those recognized by nMAbs 4C4, 6D11, 4G3 and 7JD1 (Fig. 1, Mateu et al., 1988 and unpublished observations) . Thus, the genetic diversity that originated during the spread of the virus in the course of one disease episode affected several epitopes at the main antigenic determinant of FMDV.
Complex antigenic structure of the 138-156 segment of VP1 of FMDV C-$8cl
The above data permit the outlining of an antigenic structure for the main antigenic site of FMDV C-S8cl (Fig. 4) . The determinant involves at least the region of VP1 between amino acids 138 and 150. Upon alignment these residues equate with positions 139 to 155 of FMDV O1 BFS 1860, matching very closely a disordered loop (amino acids 137 to 156) on the virion surface (Acharya et al., 1989) . One group of nMAbs (7CAll, 7JD1 and 4G3) interacts with the hypervariable segment located immediately to the carboxy-terminal side of the conserved Arg(141)-Gty-Asp-Leu-Ala(145) (R-G-D-L-A) sequence (Fig. 4) . For example, nMAb 4G3 defines an epitope that lies between amino acids 144 and 156, involving at least residues 146, 148, 149 and 150 (compare Table 1 and Fig. 2b and 3) . Another group includes the majority of VPl-specific nMAbs elicited against FMDV C-S8cl, C1 Brescia or C3 Indaial, including SD6, 5A2, 6Dll, 4C4 and 7AH1. These nMAbs define different epitopes, which have as a common feature the participation of residues at both sides of the conserved R-G-D-L-A stretch (Fig. 4) . A pivotal role for the amino acid at position 146 on the antigenic structure of the major determinant of FMDV C-S8cl is suggested by the results (Fig. 3 and 4 , see also Discussion).
We conclude that the 138-156 VP1 region of FMDV C-S8cl contains multiple overlapping epitopes. One conservative amino acid substitution, His(146) -~ Arg, is sufficient to eliminate all the epitopes probed.
Discussion
The three-dimensional structure of FMDV of serotype O (strain O1 BFS 1860; Acharya et al., 1989) has revealed that the region of VP1 between residues 137 and 156 is a disordered loop on the virion surface; this segment constitutes the major antigenic site of FMDV (Strohmaier et al., 1982; Pfaff et al., 1982; Bittle et al., 1982) . The loop includes the conserved sequence Arg-Gly-Asp, probably part of the cell attachment site , flanked by two hypervariable regions, nMAbs SD6 , 5A2, 6Dll and 7AH1 were elicited by different FMDVs of serotype C and each recognizes a different epitope that involves the two hypervariable regions surrounding the Arg-Gly-Asp sequence. In addition nMAbs SA3, SA4, SB10, SC9 and 4F1 appear to recognize the same epitope as MAb SD6 (compare Table 1 and Fig. 4) . These results suggest immunodominance of this group of related epitopes in FMDV of serotype C. Of a total of 36 nMAbs, 23 were VPl-specific and 20 recognized synthetic peptides representing the VP1 sequence 138-156 of FMDV C-$8cl. The epitopes recognized by those 20nMAbs involved at least some residues from segments 138-140 and 146-150. These observations suggest that segment 138-150 of VP1, which matches very closely the disordered loop of FMDV-O~ BFS (Fig. 5) , is the major antigenic determinant of FMDV of serotype C. Bolwell et al. (1989) have defined three epitopes in the 138-154 VP1 segment of FMDV A22 Iraq 24/64. Despite little homology between the predicted loop residues of FMDV C-S8cl and A22 Iraq 24/64 (Fig. 5) , the two viruses share a number of antigenic properties. Most nMAbs raised against these viruses recognize virion conformation-independent epitopes located in the FMDV loop. In both viruses epitopes are found that include residues from the two hypervariable regions around the Arg-Gly-Asp segment; other epitopes involve only the region at the carboxy-terminal side of the determinant. Several of the epitopes overlap. Finally, substitutions at an equivalent position, residue 146 in FMDV C-S8cl or 150 in A22 Iraq 24/64 (Fig. 5) , were the most frequent among MAb-resistant mutants isolated with these viruses. Thus, the general antigenic features of (Acharya et al., 1989) , Az2 Iraq 24/64 (Bolwell et al., 1989) and C-S8cl (Sobrino et al., 1986) . The VP1 residues (single-letter code) have been aligned to provide the maximum nucleotide sequence homology among 15 different FMDVs of serotypes A, O and C (Dopazo et al., 1988) . A dot in the sequence indicates deletion of one amino acid. A line above the sequence of FMDV O1 BFS indicates the VP1 G-H loop of this virus (Acharya et aL, 1989) . The conserved RGD (Arg-Gly-Asp) sequence is boxed with a discontinuous line. The major antigenic site of FMDV A22 Iraq and that of FMDV C-S8cl are boxed with a solid line. Symbols for amino acids found to be involved in epitopes within these antigenic sites are enhanced.
the main determinant of VP1 appear to be maintained in FMDVs of serotypes C and A. This was not the case when viruses of serotypes A and O were compared (Bolwell et al., 1989) . Data in Fig. 1 and 3 and in Mateu et al. (1988) suggest the presence of at least 10 distinguishable epitopes in the antigenic loop of FMDV C-S8cl. It is likely that, as more nMAbs are tested, additional epitopes will be found within this short amino acid stretch. Harrison (1989) has suggested that, as with a peptide in solution, the FMDV loop has no unique conformation; it can adopt, with little cost in free energy, the conformation required to interact with any antibody elicited against a peptide represented in the loop sequence. In this view, the overlapping epitopes defined by our anti-virus nMAbs would correspond to multiple immunogenic conformations of the flexible loop on the virion. Each of them will induce the synthesis of antibodies that will recognize the loop when present in the appropriate conformation. Rowlands et al. (1983) and Geysen et al. (1984 Geysen et al. ( , 1985 identified several positions in the VP1 region around amino acids 140 to 160 of FMDV that, when changed, resulted in a decrease in reactivity of the antigen with guinea-pig or rabbit antiviral sera. Use of MAbs has permitted further probing of the effect of substitutions on the interaction between FMDV and a specific antibody molecule. Conservative, frequently occurring amino acid replacements, which were fixed in VP1 of FMDV type C during a disease episode, greatly diminished the binding of nMAb SD6 to VP1 or to virions . Since the relevant substitutions were Ala(138) --, Thr and Leu(147) --, lie or Leu(147) ~ V al, we suggested that the decreased interaction could result from restriction of local mobility imposed by the bulky radicals on the/%carbon of Thr, lie and Val, thus impairing the display of the conformation recognized by nMAb SD6. The free energy expended in distorting the peptide chain to fit the antibody-combining site would probably result in reduced binding affinity (Dyson et al., 1988) . In the present report we have extended to other nMAbs the previous analysis with SD6 and shown that whereas some replacements affected only one epitope, most of them affected several epitopes (Fig.  4) and the substitution His(146) ~ Arg greatly decreased the reactivity with all nMAbs tested. This is a chemically conservative substitution (Dayhoff et al., 1972) , displaying a high degree of acceptance during protein evolution (Feng et al., 1985) . It is also noteworthy that out of seven possible amino acid replacements at this position, all with a similar degree of acceptability (Feng et al., 1985) , only His ~ Arg was repeatedly selected for in SD6 and 4G3 MAb-resistant mutants and Table 3 ). Remarkably, when the replacement His ~ Arg was introduced at the relevant position of a synthetic hexapeptide that exactly represented positions 143 to 148 of FMDV C-S8cl VP1, it was not scored as antigenicaUy significant regarding the reaction of the peptides with rabbit anti-FMDV serum (Geysen et al., 1985) . Among other possibilities, our nMAbs may not reflect the antibody composition of the serum used by Geysen and colleagues, or the hexapeptide used may have been shorter than required to represent in their entirety most of the epitopes that we have defined in the 138-156 VP1 region.
A pivotal antigenicity role for the amino acid at VP1 position 146 is also supported by a previous study of virus variants recovered from cattle persistently infected with FMDV C3 (Gebauer et al., 1988) . At the equivalent position in VP1 of FMDV C3 (residue 148 in Fig. 5 of Gebauer et al., 1988) , the parental C3 clones and viruses 783/63 and 788/63 recovered from cattle had Asp or His. They all reacted with nMAbs whose corresponding epitopes have now been positioned at the 138-156 site (compare Table 2 in Gebauer et al., 1988 and Fig. 4) . In contrast, variant 785/63 from carrier cattle included Asp --, Gin at the relevant position as the only replacement in this VP1 segment and did not react with most of the above MAbs (Table 2 in Gebauer et al., 1988) . Thus, VP1 substitution Asp(148)~ Gin in FMDV C3 paralleled the effect of His(146)--* Arg in the equivalent position of FMDV C-S8cl, as regards loss of reactive epitopes.
The above results indicate that a single critical replacement fixed in the FMDV loop may have a strong effect on its antigenicity by affecting many epitopes within that site. This leads to an important phenotypic amplification of a modest genetic modification. Thus, a low level of genetic heterogeneity, such as the one found among viruses of a single disease episode that differed in about 0.7~ to 2.2~ of nucleotides (Domingo et 
